Featured Content
The Patient Behind the EHR: Oncologists Only See Half the Picture
Dr Vorobiof discusses the importance patient factors that can be missed via standard data collection methods for patients with cancer.
Who Determines What 'Value' Looks Like in Value-Based Cancer Care?
Evaluation of patient-reported outcomes (PROs) is an important component of measuring quality in cancer care.
Reclassification of Variants of Uncertain Significance: A Q&A With Theodora Ross MD, PhD
Dr Ross described how genomic reports may need to be updated to account for new insights into a variant's role in cancer.
Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
A ctDNA testing method has the capability to predict cancer recurrence, which could help guide therapy selections and uncover new drug development opportunities.More Features>>>
Endocrine Cancer News
Molecular Testing May Prevent Unnecessary Treatment of Suspicious for Malignancy Thyroid Nodules
October 05, 2018
MEK1/2 Inhibitor After RAI Fails to Improve Outcomes in High-Risk Nonmetastatic Thyroid Cancer
October 04, 2018
Endocrine Cancer Resources
More Information
Nutraceuticals/Supplements and Cancer Prevention: All Hype?
November 09, 2018
This fact sheet discusses the research on supplement use and cancer incidence.
Familial Exposure to Radiation During Treatment for Cancer
October 26, 2018
This fact sheet discusses the risk of familial exposure to radiation during cancer treatment and strategies to help limit incidental contact with potentially harmful byproducts.
Plastics and Cancer
October 19, 2018
Few studies have evaluated the general exposure to plastics and cancer risk, and data on cancer risk among workers in the plastic industry are inconclusive.
A Vegan Diet and Cancer
October 12, 2018
There are no data on whether a vegan diet is an effective means of cancer prevention among high-risk populations.
Tissue Biopsy: What to Expect
October 05, 2018
This fact sheet informs patients about what to expect prior to, during, and after a tissue biopsy.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Prostate Cancer | Regimens | Drugs |
| Rare Cancers | Regimens | |
| Renal Cell Carcinoma | Regimens | Drugs |
| Skin Cancer | Regimens | Drugs |
| Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Nutraceuticals/Supplements and Cancer Prevention: All Hype?
- Encorafenib Plus Binimetinib Offers a New Option for MEK+BRAF Inhibition
- Daratumumab Plus Lenalidomide and Dexamethasone May Benefit Some Patients With MM
- BRCA1 Mutation Observed to Confer Heightened Risk of Colorectal Cancer
- Proteomics Study Reveals New Medulloblastoma Subtypes and Potential Novel Treatment Targets
- Nutraceuticals/Supplements and Cancer Prevention: All Hype?
- Plastics and Cancer
- Encorafenib Plus Binimetinib Offers a New Option for MEK+BRAF Inhibition
- Reclassification of Variants of Uncertain Significance: A Q&A With Theodora Ross MD, PhD
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- H. pylori Eradication Did Not Result in Platelet Recovery for All Chronic ITP Cases
- Posttransplant AML Relapse Linked to Pathways Influencing Immune Function
- New Algorithm Improves Outcome Prediction for Diffuse Large B-Cell Lymphoma
- Immunotherapy Combo in Head and Neck Cancer Shows Activity in Phase 2 Trial
- Prototype Intervention Increased Adherence to TKIs in CML